Burdon Peter C E, Martin Coralie, Rankin Sara M
Leukocyte Biology Section, Division of Biomedical Sciences, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Bldg, Exhibition Rd, South Kensington, London SW7 2AZ, United Kingdom.
Blood. 2005 Mar 15;105(6):2543-8. doi: 10.1182/blood-2004-08-3193. Epub 2004 Nov 12.
The acute release of neutrophils from the bone marrow is a critical step in their trafficking to sites of inflammation. This process is stimulated by systemically acting inflammatory mediators, such as the CXC chemokines. In this study we have used a novel in situ perfusion system of the rat femoral bone marrow to directly investigate the role of specific adhesion molecules in chemokine-stimulated neutrophil mobilization. We show here that neutrophils mobilized in response to rat macrophage inflammatory protein-2 (MIP-2) shed L-selectin and expressed significantly higher levels of CD11b and CD49d. However, inhibition of L-selectin sheddase activity with KD-IX-73-4 had no effect on the number of neutrophils mobilized in response to rat MIP-2. Blockade of CD18, using a neutralizing monoclonal antibody (mAb), did not inhibit neutrophil mobilization but unexpectedly increased the rate and number of neutrophils released from the bone marrow in response to chemokine, suggesting that CD18 could play a role in neutrophil retention within the bone marrow. Blockade of CD49d using either a selective mAb or a specific antagonist resulted in a dramatic inhibition (> 75%) of the chemokine-stimulated neutrophil mobilization from the bone marrow. These data reveal contrasting roles for CD18 and CD49d in the retention and release of neutrophils from the bone marrow.
骨髓中嗜中性粒细胞的急性释放是其向炎症部位迁移的关键步骤。这一过程受到全身性作用的炎症介质(如CXC趋化因子)的刺激。在本研究中,我们使用了一种新型的大鼠股骨骨髓原位灌注系统,直接研究特定黏附分子在趋化因子刺激的嗜中性粒细胞动员中的作用。我们在此表明,响应大鼠巨噬细胞炎性蛋白-2(MIP-2)而动员的嗜中性粒细胞会脱落L-选择素,并显著上调CD11b和CD49d的表达水平。然而,用KD-IX-73-4抑制L-选择素裂解酶活性对响应大鼠MIP-2而动员的嗜中性粒细胞数量没有影响。使用中和单克隆抗体(mAb)阻断CD18并不抑制嗜中性粒细胞的动员,但出乎意料的是,它会增加趋化因子刺激下骨髓中嗜中性粒细胞的释放速率和数量,这表明CD18可能在嗜中性粒细胞在骨髓中的滞留中起作用。使用选择性mAb或特异性拮抗剂阻断CD49d会导致趋化因子刺激的骨髓嗜中性粒细胞动员受到显著抑制(>75%)。这些数据揭示了CD18和CD49d在骨髓中嗜中性粒细胞的滞留和释放中所起的相反作用。